Could extra white cells boost immune recovery in kids with tough leukemia?
NCT ID NCT05425043
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether giving children with hard-to-cure leukemia a transfusion of white blood cells (granulocytes) after a cord blood transplant helps their new immune system grow faster and safer. About 40 children under 16 will receive this extra transfusion, and researchers will check for side effects like cytokine release syndrome and whether the treatment helps control leukemia without causing graft-versus-host disease. The goal is to improve recovery and reduce complications in kids who need a transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Manchester Childrens Hospital, MFT
Manchester, M13 9WL, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's DNA guide better cancer care for kids?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- A guided path back to work after blood cancer: a trial tests the impact
- Can a new tracer light up cancer growth?
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Can a different immune drug cut viral infections after stem cell transplants?